172 related articles for article (PubMed ID: 19165720)
21. Insertion of anthrax protective antigen into liposomal membranes: effects of a receptor.
Sun J; Vernier G; Wigelsworth DJ; Collier RJ
J Biol Chem; 2007 Jan; 282(2):1059-65. PubMed ID: 17107945
[TBL] [Abstract][Full Text] [Related]
22. A protective antigen mutation increases the pH threshold of anthrax toxin receptor 2-mediated pore formation.
Dennis MK; Mogridge J
Biochemistry; 2014 Apr; 53(13):2166-71. PubMed ID: 24641616
[TBL] [Abstract][Full Text] [Related]
23. Identification of new dominant-negative mutants of anthrax protective antigen using directed evolution.
Wu G; Feng C; Cao S; Guo A; Liu Z
Appl Biochem Biotechnol; 2012 Nov; 168(5):1302-10. PubMed ID: 22948605
[TBL] [Abstract][Full Text] [Related]
24. Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity.
Panchal RG; Halverson KM; Ribot W; Lane D; Kenny T; Abshire TG; Ezzell JW; Hoover TA; Powell B; Little S; Kasianowicz JJ; Bavari S
J Biol Chem; 2005 Mar; 280(11):10834-9. PubMed ID: 15644338
[TBL] [Abstract][Full Text] [Related]
25. Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting.
Chen KH; Liu S; Leysath CE; Miller-Randolph S; Zhang Y; Fattah R; Bugge TH; Leppla SH
J Biol Chem; 2016 Oct; 291(42):22021-22029. PubMed ID: 27555325
[TBL] [Abstract][Full Text] [Related]
26. Microbiology. Translocation of anthrax toxin: lord of the rings.
von Heijne G
Science; 2005 Jul; 309(5735):709-10. PubMed ID: 16051774
[No Abstract] [Full Text] [Related]
27. The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor.
Singh Y; Klimpel KR; Arora N; Sharma M; Leppla SH
J Biol Chem; 1994 Nov; 269(46):29039-46. PubMed ID: 7961869
[TBL] [Abstract][Full Text] [Related]
28. Ion selectivity of the anthrax toxin channel and its effect on protein translocation.
Schiffmiller A; Anderson D; Finkelstein A
J Gen Physiol; 2015 Aug; 146(2):183-92. PubMed ID: 26170174
[TBL] [Abstract][Full Text] [Related]
29. Probing the pH-dependent prepore to pore transition of Bacillus anthracis protective antigen with differential oxidative protein footprinting.
Smedley JG; Sharp JS; Kuhn JF; Tomer KB
Biochemistry; 2008 Oct; 47(40):10694-704. PubMed ID: 18785752
[TBL] [Abstract][Full Text] [Related]
30. A receptor-based switch that regulates anthrax toxin pore formation.
Pilpa RM; Bayrhuber M; Marlett JM; Riek R; Young JA
PLoS Pathog; 2011 Dec; 7(12):e1002354. PubMed ID: 22174672
[TBL] [Abstract][Full Text] [Related]
31. Cross-linked forms of the isolated N-terminal domain of the lethal factor are potent inhibitors of anthrax toxin.
Juris SJ; Melnyk RA; Bolcome RE; Chan J; Collier RJ
Infect Immun; 2007 Oct; 75(10):5052-8. PubMed ID: 17635861
[TBL] [Abstract][Full Text] [Related]
32. Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells.
Chen KH; Liu S; Bankston LA; Liddington RC; Leppla SH
J Biol Chem; 2007 Mar; 282(13):9834-9845. PubMed ID: 17251181
[TBL] [Abstract][Full Text] [Related]
33. Changing the receptor specificity of anthrax toxin.
Mechaly A; McCluskey AJ; Collier RJ
mBio; 2012; 3(3):. PubMed ID: 22550037
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the interaction between anthrax toxin and its cellular receptors.
Liu S; Leung HJ; Leppla SH
Cell Microbiol; 2007 Apr; 9(4):977-87. PubMed ID: 17381430
[TBL] [Abstract][Full Text] [Related]
35. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
Stiles L; Nelson DJ
J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
[TBL] [Abstract][Full Text] [Related]
36. Identification of residues lining the anthrax protective antigen channel.
Benson EL; Huynh PD; Finkelstein A; Collier RJ
Biochemistry; 1998 Mar; 37(11):3941-8. PubMed ID: 9521715
[TBL] [Abstract][Full Text] [Related]
37. Characterization of dominant-negative forms of anthrax protective antigen.
Yan M; Collier RJ
Mol Med; 2003; 9(1-2):46-51. PubMed ID: 12765339
[TBL] [Abstract][Full Text] [Related]
38. Anthrax toxin receptor drives protective antigen oligomerization and stabilizes the heptameric and octameric oligomer by a similar mechanism.
Kintzer AF; Sterling HJ; Tang II; Williams ER; Krantz BA
PLoS One; 2010 Nov; 5(11):e13888. PubMed ID: 21079738
[TBL] [Abstract][Full Text] [Related]
39. Monitoring anthrax toxin receptor dissociation from the protective antigen by NMR.
Rajapaksha M; Eichler JF; Hajduch J; Anderson DE; Kirk KL; Bann JG
Protein Sci; 2009 Jan; 18(1):17-23. PubMed ID: 19177347
[TBL] [Abstract][Full Text] [Related]
40. Solubilization and characterization of the anthrax toxin pore in detergent micelles.
Vernier G; Wang J; Jennings LD; Sun J; Fischer A; Song L; Collier RJ
Protein Sci; 2009 Sep; 18(9):1882-95. PubMed ID: 19609933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
